歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > Microbiology/Virology > Clinafloxacin

瀏覽歷史

S80061

Clinafloxacin

源葉(MedMol) 98%
  • 英文名:
  • Clinafloxacin
  • 別名:
  • 克林沙星;7-(3-氨基-1-吡咯烷基)-1-環(huán)丙基-6-氟-8-氯-1,4-二氫-4-氧代-3-喹啉羧酸;1-環(huán)丙基-6-氟-7-(3-氨基吡咯烷-1- 基)-8-氯-1,4-二氫-4-氧-喹啉-3-羧酸;可林沙星;7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-8-chloro-1,4-dihydro-4-oxo-3-quinolinecar
  • CAS號:
  • 105956-97-6
  • 分子式:
  • C17H17ClFN3O3
  • 分子量:
  • 365.787
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S80061-10mg 98% ¥380.00元 6 - - - EA 加入購物車
源葉(MedMol) S80061-50mg 98% ¥800.00元 6 - - - EA 加入購物車
源葉(MedMol) S80061-250mg 98% ¥2400.00元 7 - - - EA 加入購物車
源葉(MedMol) S80061-1g 98% ¥8000.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(1篇)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Clinafloxacin (AM 1091) is a potent and broad-spectrum fluoroquinolone antibiotic, has inhibitory activity against gram-positive, gram-negative bacterias, and anaerobic pathogens in vitro. Clinafloxacin is against DNA gyrase and topoisomerase IV of S. aureus with IC50 values of 0.92 μg/ml and 1.62 μg/ml, respectively
  • 靶點(diǎn): Quinolone;Antibacterial;Antibiotic
  • 體內(nèi)研究:
    Clinafloxacin is very effective for the therapy of penicillin-resistant, ciprofloxacin-susceptible pneumococcal meningitis in the rabbit model. With the CS strain (2349)(Clinafloxacin MIC=0.12 μg/ml), at a dose of 10 mg/kg and 20 mg/kg per day Clinafloxacin achieves an initial reduction at 6 hr. Both are bactericidal at this point but presents regrowth at 24 hr, and the final reduction at 24 hr in mean log cfu/ml is 22.30 and 23.83, respectively. However, With the CR strain (4371)(Clinafloxacin MIC=0.5 μg/ml), Clinafloxacin even at 20 mg/kg per day does not decrease bacterial titers at any time point in this rabbit model of meningitis.
  • 參考文獻(xiàn):
    1. M Takei, et al. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.Antimicrob Agents Chemother. 2001 Dec;45(12):3544-7. 2. Randa H Abdelkreem, et al. DNA Gyrase and Topoisomerase IV Mutations and their effect on Quinolones Resistant Proteus mirabilis among UTIs Patients. Pak J Med Sci. Sep-Oct 2020;36(6):1234-1240. 3. A Domenech, et al. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.Microb Drug Resist. 2003;9 Suppl 1:S53-9.
  • 溶解性: DMSO  :  2  mg/mL  (5.47  mM;  ultrasonic  and  warming  and  heat  to  80°C)
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.734 ml 13.669 ml 27.338 ml
    5 mM 0.547 ml 2.734 ml 5.468 ml
    10 mM 0.273 ml 1.367 ml 2.734 ml
    50 mM 0.055 ml 0.273 ml 0.547 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。